Milestone Pharmaceuticals INC. (MIST) — 10-Q Filings

All 10-Q filings from Milestone Pharmaceuticals INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Milestone Pharma's Net Loss Widens Amid Increased Commercial Spend — Nov 12, 2025 Risk: high
Milestone Pharmaceuticals Inc. reported a net loss of $11.922 million for the three months ended September 30, 2025, an increase from a net loss of $9.439 milli
Milestone Pharma Continues Burn, Eyes Etripamil Progress — Aug 12, 2025 Risk: high
Milestone Pharmaceuticals Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company's net l
Milestone Pharma Files Q1 2025 10-Q — May 14, 2025 Risk: low
Milestone Pharmaceuticals Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including common stock and additio
Milestone Pharma Q3 2024 10-Q Filed — Nov 12, 2024 Risk: low
Milestone Pharmaceuticals Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the
Milestone Pharmaceuticals Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
Milestone Pharmaceuticals Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and provided updates on its business o
Milestone Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: low
Milestone Pharmaceuticals Inc. (MIST) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Milestone Pharmaceuticals Inc. filed a 10-Q report for the p

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX